Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc.

Assembly Biosciences, Inc. is a clinical-stage biotechnology company developing two innovative platform programs: an HBV program advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and a microbiome program developing novel oral live biotherapeutics designed to address diseases associated with the microbiome.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ASMB” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.assemblybio.com
Founded2014
Disease Focus
Development StageClinical
STOCK CODENASDAQ: ASMB
Address
11711 North Meridian Street Suite 310, IN 46032
Carmel
United States
Email
Contact Number
+1 646 746 8002

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/ventrus-biosciences” connections=”true” suffix=””]